Regal Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.8M Buy
101,511
+2,884
+3% +$276K 0.51% 47
2025
Q4
$9.47M Buy
98,627
+7,755
+9% +$753K 0.57% 37
2025
Q3
$8.65M Sell
90,872
-40
-0% -$3.68K 0.56% 41
2025
Q2
$7.93M Buy
90,912
+274
+0.3% +$23.2K 0.59% 40
2025
Q1
$8.14M Sell
90,638
-24,410
-21% -$2.18M 0.66% 35
2024
Q4
$9.19M Buy
115,048
+1,491
+1% +$129K 0.69% 32
2024
Q3
$10.2M Buy
113,557
+5,353
+5% +$450K 0.72% 24
2024
Q2
$8.52M Buy
108,204
+6,858
+7% +$562K 0.56% 42
2024
Q1
$8.83M Sell
101,346
-1,388
-1% -$118K 0.6% 36
2023
Q4
$8.46M Buy
102,734
+109
+0.1% +$8.31K 0.64% 35
2023
Q3
$8.04M Buy
102,625
+8,847
+9% +$741K 0.68% 32
2023
Q2
$8.26M Buy
93,778
+6,507
+7% +$560K 0.69% 33
2023
Q1
$7.04M Buy
87,271
+12,327
+16% +$1M 0.62% 41
2022
Q4
$5.82M Buy
74,944
+6,502
+10% +$527K 0.56% 48
2022
Q3
$5.53M Buy
68,442
+7,850
+13% +$705K 0.58% 47
2022
Q2
$5.44M Buy
60,592
+7,701
+15% +$780K 0.57% 46
2022
Q1
$5.87M Buy
52,891
+5,079
+11% +$537K 0.54% 48
2021
Q4
$4.95M Buy
47,812
+2,046
+4% +$237K 0.44% 58
2021
Q3
$5.74M Buy
45,766
+4,939
+12% +$639K 0.56% 40
2021
Q2
$5.07M Buy
+40,827
New +$5.13M 0.51% 48
2021
Q1
Sell
-47,318
Closed -$5.54M 272
2020
Q4
$5.54M Buy
+47,318
New +$5.21M 0.63% 39
2020
Q3
Sell
-49,010
Closed -$4.49M 162
2020
Q2
$4.49M Buy
+49,010
New +$4.7M 0.82% 30
2020
Q1
Sell
-40,901
Closed -$4.64M 197
2019
Q4
$4.64M Sell
40,901
-138
-0.3% -$15.1K 0.83% 29
2019
Q3
$4.46M Sell
41,039
-3,167
-7% -$330K 0.87% 26
2019
Q2
$4.3M Buy
44,206
+4,688
+12% +$428K 0.84% 28
2019
Q1
$3.6M Buy
39,518
+6,754
+21% +$604K 0.73% 34
2018
Q4
$2.98M Buy
32,764
+6,833
+26% +$639K 0.65% 43
2018
Q3
$2.55M Buy
25,931
+17,157
+196% +$1.59M 0.54% 46
2018
Q2
$751K Sell
8,774
-1,263
-13% -$105K 0.23% 130
2018
Q1
$805K Buy
10,037
+4,563
+83% +$376K 0.18% 142
2017
Q4
$442K Buy
5,474
+2,616
+92% +$210K 0.1% 190
2017
Q3
$222K Buy
+2,858
New +$237K 0.05% 252
2015
Q4
Sell
-991
Closed -$66K 631
2015
Q3
$66K Sell
991
-4,111
-81% -$303K 0.02% 399
2015
Q2
$378K Buy
5,102
+89
+2% +$6.8K 0.1% 176
2015
Q1
$391K Buy
5,013
+459
+10% +$34.8K 0.1% 178
2014
Q4
$329K Buy
4,554
+372
+9% +$25.8K 0.09% 177
2014
Q3
$259K Buy
4,182
+796
+24% +$50.6K 0.08% 201
2014
Q2
$216K Buy
3,386
+1,369
+68% +$83.2K 0.08% 198
2014
Q1
$124K Buy
2,017
+1,914
+1,858% +$111K 0.05% 238
2013
Q4
$6K Sell
103
-150
-59% -$8.51K ﹤0.01% 658
2013
Q3
$13K Hold
253
0.01% 553
2013
Q2
$13K Buy
+253
New +$12.5K 0.01% 538

Other funds holding MDT

Regal Investment Advisors's MDT Position: Q1 2026 in Review

Regal Investment Advisors increased its Medtronic (MDT) stake by 2.9% in Q1 2026, buying an estimated $276K and bringing the position to 101,511 shares worth $8.8M. The position accounts for 0.51% of the portfolio, ranked #47.

Regal Investment Advisors first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $10.2M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Regal Investment Advisors held 101,511 shares of Medtronic worth $8.8M as of Q1 2026.
  • Regal Investment Advisors bought 2,884 Medtronic shares in Q1 2026, an estimated $276K.
  • Medtronic made up 0.51% of Regal Investment Advisors's portfolio in Q1 2026, its #47 holding.
  • Regal Investment Advisors first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
  • Regal Investment Advisors's Medtronic position peaked at $10.2M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.